Delivering innovative solutions by connecting technology and business to drive sustainable growth
08 June 2021
Andreas Fischer (CIO)
As ONE Evonik, innovation is deeply rooted in group strategy Leading beyond chemistry to drive sustainable growth and profitability
Ongoing portfolio transformation
- Target: Specialty portfolio with 100% growth businesses
Ambitious financial targets
- EBITDA margin: 18-20%
- Cash conversion ratio: >40%
- ROCE: 11%
LEADING
BEYOND
CHEMISTRY
Innovation & Sustainability as growth drivers
- €1 bn additional sales from innovation growth fields by 2025
- Growing portfolio share of "Next Generation Solutions"
Performance-driven corporate culture
-
Further drive
gender and cultural diversity - Deliver on efficiency programs in Administration & Operations
2 | 08 June 2021 | Andreas Fischer | Research & Development
The ONE Evonik strategy is reflected in our new RD&I setup
ONE Evonik
Executive Board
Divisions
Specialty | Nutrition & | Smart | Performance | Technology & | |||||
Additives | Care | Materials | Materials | Infrastructure | |||||
Regions
Research, Development &
Innovation
ONE RD&I
Research, Development &
Innovation
R&D Nutrition & Care
R&D Resource Efficiency
R&D Performance Materials
Creavis
Evonik Venture Capital
Steering
ONE Portfolio
- Leverage Synergies ("Speed of Light" - mRNA)
- Integrate sustainability in portfolio management by PARC analysis
3 | 08 June 2021 | Andreas Fischer | Research & Development
Our strategy
with an aligned set of goals contributing to Evonik's success
We deliver innovative solutions by connecting technology & business to drive sustainable growth
Sustainability | Growth & Profitability | Platform Technologies | |||||
We develop sustainable solutions | We create opportunities | We make the best use | |||||
as a key factor in decision-making and key | to achieve our financial target of €1 bn | of our resources with shared technology | |||||
success factor for future growth | additional sales by 2025 with products of | platforms and focus on our most promising | |||||
our six innovation growth fields | projects |
- Deliver R&D on new product and processes
- Create & grow businesses beyond core
- Recruit and develop new talents
Our activities…
- Steer portfolio and optimize resource allocation
- Manage partnerships with key customers, startups and universities
- Build reputation as a seal of quality for customers, investors, employees and talents
4 | 08 June 2021 | Andreas Fischer | Research & Development
Bundling our biotechnology competencies into one platform Consistent focus on future topics
Biotechnology Platform | ||||||||
Program & Project Management | ||||||||
Systems Biotechnology | Process Biotechnology | |||||||
In silico | Target | Microbial | | ~200 employees | ||||
Factory | Process Design | | > 100 products | |||||
Systems | Systems | |||||||
Systems | | Success Stories | ||||||
| Gut Health Solutions | |||||||
| Veramaris | |||||||
| Biosurfactants |
Lab Operations
5 | 08 June 2021 | Andreas Fischer | Research & Development
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Evonik Industries AG published this content on 08 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2021 07:56:07 UTC.